Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
61 results:
1. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract] [Full Text] [Related]
2. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
3. Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid leukemia by Targeting XPO1/eIF4E/c-MYC Signaling.
Long H; Hou Y; Li J; Song C; Ge Z
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047788
[TBL] [Abstract] [Full Text] [Related]
4. Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment.
Karadaş N; Göktepe ŞŞÖ; Baş İ; Ece D; Özdemir HH; Balkan C; Kavaklı K; Aydinok Y; Karapinar DY
Int J Hematol; 2023 Mar; 117(3):446-455. PubMed ID: 36401784
[TBL] [Abstract] [Full Text] [Related]
5. Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Whitlock JA; Malvar J; Dalla-Pozza L; Goldberg JM; Silverman LB; Ziegler DS; Attarbaschi A; Brown PA; Gardner RA; Gaynon PS; Hutchinson R; Huynh VT; Jeha S; Marcus L; Messinger Y; Schultz KR; Cassar J; Locatelli F; Zwaan CM; Wood BL; Sposto R; Gore L
Pediatr Blood Cancer; 2022 Nov; 69(11):e29901. PubMed ID: 35989458
[TBL] [Abstract] [Full Text] [Related]
6. [The correlation of CD49d expression pattern with molecular genetics and hotspot gene mutants in patients with chronic lymphocytic leukemia].
Zhu J; Liu L; Chen X; Liu F; Zhao SS; Jin HM; Qiu HR; Qiao C; Li JY; Wu YJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):463-468. PubMed ID: 35968588
[No Abstract] [Full Text] [Related]
7. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.
Pagano L; Criscuolo M; Broccoli A; Piciocchi A; Varettoni M; Galli E; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Frustaci A; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Offidani M; Casadei B; Nizzoli ME; De Luca ML; Fianchi L; Motta M; Guarnera L; Simonetti E; Visentin A; Vassallo F; Deodato M; Sarlo C; Olivieri A; Falini B; Pulsoni A; Tiacci E; Zinzani PL
Blood Cancer J; 2022 Jul; 12(7):109. PubMed ID: 35853850
[TBL] [Abstract] [Full Text] [Related]
8. The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years.
Bazarbachi A; Boumendil A; Finel H; Khvedelidze I; Romejko-Jarosinska J; Tanase A; Akhtar S; Ben Othman T; Ma'koseh M; Afanasyev B; Cheikh J; Briones J; Gülbas Z; Hamladji RM; Elverdi T; Blaise D; Martínez C; Alma E; Halaburda K; Sousa AB; Glass B; Robinson S; Montoto S; Sureda A
Leukemia; 2022 Jun; 36(6):1646-1653. PubMed ID: 35414657
[TBL] [Abstract] [Full Text] [Related]
9. Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.
Yu H; Wu S; Liu S; Li X; Gai Y; Lin H; Wang Y; Edwards H; Ge Y; Wang G
J Cell Mol Med; 2022 May; 26(9):2646-2657. PubMed ID: 35355406
[TBL] [Abstract] [Full Text] [Related]
10. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
[TBL] [Abstract] [Full Text] [Related]
11. A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Martínez Sánchez MP; Megías-Vericat JE; Rodríguez-Veiga R; Vives S; Bergua JM; Torrent A; Suárez-Varela S; Boluda B; Martínez-López J; Cano-Ferri I; Acuña-Cruz E; Torres-Miñana L; Martín-Herreros B; Serrano A; Sempere A; Barragán E; Sargas C; Sanz M; Martínez-Cuadrón D; Montesinos P;
Ann Hematol; 2021 Jun; 100(6):1497-1508. PubMed ID: 33914097
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia.
Wang J; Pan J; Huang S; Li F; Huang J; Li X; Ling Q; Ye W; Wang Y; Yu W; Jin J
BMC Med; 2021 Feb; 19(1):28. PubMed ID: 33517886
[TBL] [Abstract] [Full Text] [Related]
13. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, birc3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
[TBL] [Abstract] [Full Text] [Related]
14. Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.
Largeaud L; Cornillet-Lefebvre P; Hamel JF; Dumas PY; Prade N; Dufrechou S; Plenecassagnes J; Luquet I; Blanchet O; Banos A; Béné MC; Bernard M; Bertoli S; Bonmati C; Fornecker LM; Guièze R; Haddaoui L; Hunault M; Ianotto JC; Jourdan E; Ojeda M; Peterlin P; Vey N; Zerazhi H; Yosr H; Mineur A; Cahn JY; Ifrah N; Récher C; Pigneux A; Delabesse E;
Leukemia; 2021 May; 35(5):1291-1300. PubMed ID: 32943750
[TBL] [Abstract] [Full Text] [Related]
15. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].
Yu J; Yi T; Lin G; Wen J; Chen L; Chen J; Wu X
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):255-261. PubMed ID: 32376526
[TBL] [Abstract] [Full Text] [Related]
17. Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid leukemia Patients.
Jiang H; Li C; Liu Z; Shengjing Hospital ;
Acta Haematol; 2020; 143(1):51-59. PubMed ID: 31434075
[TBL] [Abstract] [Full Text] [Related]
18. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
19. Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.
Brück O; Blom S; Dufva O; Turkki R; Chheda H; Ribeiro A; Kovanen P; Aittokallio T; Koskenvesa P; Kallioniemi O; Porkka K; Pellinen T; Mustjoki S
Leukemia; 2018 Jul; 32(7):1643-1656. PubMed ID: 29925907
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical analysis of 70 chronic lymphocytic leukemia patients with trisomy 12 detected by FISH].
Lyu R; Li ZJ; Li H; Yi SH; Liu W; Wang TY; Xiong WJ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):387-391. PubMed ID: 29779347
[No Abstract] [Full Text] [Related]
[Next]
